Feng Zhengzhe, Fang Yibin, Xu Yi, Hong Bo, Zhao Wenyuan, Liu Jianmin, Huang Qinghai
Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai, China.
J Neurointerv Surg. 2016 Nov;8(11):1192-1196. doi: 10.1136/neurintsurg-2015-012090. Epub 2016 Jan 8.
The low profile visualized intraluminal support (LVIS) device is a new generation of self-expanding braided stents recently introduced into China for stent assisted coiling of intracranial aneurysms. This study assessed the clinical safety and efficacy of the LVIS stent for embolization of intracranial saccular aneurysms.
Patients with intracranial saccular aneurysms treated using the LVIS device in our center between April 2014 and December 2014 were reviewed. The primary outcomes were procedural safety, target aneurysm recurrence, and mid-term follow-up of clinical and angiographic outcomes.
97 patients with intracranial saccular aneurysms were treated using the LVIS stent, with 100% technical success rate. No mortality was observed. One patient had transient deficit (1/97, 1.0%). Immediate angiographic outcome evaluation showed complete occlusion in 28 (28.8%) and neck remnant in 39 (40.2%) of the 97 patients, respectively. Of the 76 (78.35%) patients who underwent angiographic follow-up at a mean of 8.1 months, complete occlusion was achieved in 64 (84.2%) patients. In the remaining patients, neck remnant in nine (11.8%) and residual sac in three (4%) patients were observed. None of the patients had any target aneurysm recurrence, and the mortality rate was 0%.
The LVIS stent is safe and effective in the treatment of intracranial saccular aneurysms.
低轮廓可视化腔内支撑(LVIS)装置是新一代自膨式编织支架,最近引入中国用于颅内动脉瘤的支架辅助弹簧圈栓塞术。本研究评估了LVIS支架用于颅内囊状动脉瘤栓塞的临床安全性和有效性。
回顾了2014年4月至2014年12月在本中心使用LVIS装置治疗的颅内囊状动脉瘤患者。主要结局指标为手术安全性、目标动脉瘤复发情况以及临床和血管造影结局的中期随访结果。
97例颅内囊状动脉瘤患者使用LVIS支架进行治疗,技术成功率为100%。未观察到死亡病例。1例患者出现短暂性神经功能缺损(1/97,1.0%)。即刻血管造影结局评估显示,97例患者中分别有28例(28.8%)完全闭塞,39例(40.2%)存在瘤颈残留。在平均8.1个月时接受血管造影随访的76例(78.35%)患者中,64例(84.2%)实现了完全闭塞。在其余患者中,观察到9例(11.8%)有瘤颈残留,3例(4%)有残腔。所有患者均未出现目标动脉瘤复发,死亡率为0%。
LVIS支架治疗颅内囊状动脉瘤安全有效。